David P. Smith

Copper-mediated Amyloid-β Toxicity Is Associated with an Intermolecular Histidine Bridge*

C. Masters, A. Bush, R. Cappai, 2006, Journal of Biological Chemistry.

Analysis of Abeta interactions using ProteinChip technology.

J. Wade, E. Giannakis, K. Barnham, 2008, Methods in molecular biology.

Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein.

S. Bottomley, C. Masters, A. Hill, 2008, Biochemistry.

Linker histone H1 binds to disease associated amyloid-like fibrils.

Colin L Masters, C. Masters, P. Crouch, 2006, Journal of molecular biology.

In Vitro Characterization of Pittsburgh Compound-B Binding to Lewy Bodies

C. Rowe, C. Masters, P. Adlard, 2007, The Journal of Neuroscience.

Dopamine promotes α‐synuclein aggregation into SDS‐resistant soluble oligomers via a distinct folding pathway

S. Bottomley, C. Masters, A. Hill, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Stabilization of neurotoxic soluble beta-sheet-rich conformations of the Alzheimer's disease amyloid-beta peptide.

S. Bottomley, C. Masters, R. Cappai, 2008, Biophysical journal.

Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-beta peptide.

C. Masters, R. Cappai, G. Ciccotosto, 2007, Biochemistry.

Dimeric structures of alpha-synuclein bind preferentially to lipid membranes.

C. Masters, R. Cappai, J. Wade, 2008, Biochimica et biophysica acta.

Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease

C. Masters, A. Bush, R. Cherny, 2008, Proceedings of the National Academy of Sciences.

The N-Terminal Residues 43 to 60 Form the Interface for Dopamine Mediated α-Synuclein Dimerisation

R. Cappai, M. Hinds, Eva Illes-Toth, 2015, PloS one.